Meishairwin, I'd believe the market does a decent job at pricing ADXS if our market cap was higher than ADRO's. The fact that it's not means something has gone wrong IMO.
I'm not sure what that is. I'm open to the possibility that trading has created a self-fulfilling prophecy that ADXS never holds gains. I'm sure we've all seen and profited from stocks which are consistently traded below their fundamental value.
The recent PPS movement of UBNT comes to mind. It gets beat down even in the presence of heavy buybacks with a long history of being very well timed.
Pop-and-fade is simply too common in biotechs for me to take their PPS too seriously.
Meishairwin you say: To me, what ADXS "should be worth now" is a pointless question. It is worth what the market will pay: $7.82/sh ($315M market cap) at the close of trading on Tuesday.
Do you (or better large inst) can get 10-15 mio shares at the price of 7.82 $? If you can answer this with YES then the ADXS is worth so much es you think.
News 
Market Data 
Discover 
AI
